Clinical Trial Update: Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease [Phase 3]

View source ↗

Summary

A Phase 3 randomized, single-blind, placebo-controlled trial comparing pramipexole and bromocriptine in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Bromocriptine (bromocriptine)
• Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED